VIROPHARMA INC: cashflow_financing
| Value | {"amount": -47620000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2011-01-01 – 2011-03-31 |
| Status | current |
| Entity | VIROPHARMA INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:38:36.520139+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9a8692e2-99ad-42e6-a893-2ccb8e3f7d02
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-11-115557 · Open the official SEC filing →Retrieved: 2026-08-19T09:38:36.520139+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000946840/cashflow-financing/2011-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9a8692e2-99ad-42e6-a893-2ccb8e3f7d02
History
- no predecessors — first report